Table 1.

Associations with clinicopathological parameters and TAMs versus TILs status

Clinicopathological parameter	CD68/CD4					CD68/CD8					CD68/CD20
	High/low	High/high	Low/high	Low/low	p value	High/low	High/high	Low/high	Low/low	p value	High/low	High/high	Low/high	Low/low	p value
Age at diagnosis (years)					0.462					0.571					0.618
< 60	11	15	14	12		13	14	14	11		13	13	14	12
≥ 60	17	10	13	15		12	14	11	18		18	9	17	11
Tumor size (cm)					0.124					0.727					0.131
≤ 2	13	15	21	17		13	18	16	19		15	13	24	14
> 2	15	10	6	10		12	10	9	10		16	9	7	9
Histological grade					0.082					0.089					0.224
I, II	6	5	7	13		5	6	5	15		7	4	10	10
III	22	20	20	14		16	26	16	18		24	18	21	13
Histology					0.080					0.020					0.498
IBC-NST	19	19	21	18		17	21	20	19		20	18	21	18
IBC-NST with medullary pattern	2	6	3	0		1	6	4	0		4	4	3	0
Ca with apocrine differentiation	4	0	3	3		3	0	1	6		4	0	4	2
Metaplastic carcinoma	2	0	0	4		3	1	0	2		2	0	2	2
ILC	1	0	0	1		0	0	0	2		1	0	1	0
IMP	0	0	0	1		1	0	0	0		0	0	0	1
Lymph node status					0.578					0.532					0.729
Absent	13	15	18	19		9	19	14	23		17	11	21	16
Present	11	6	7	6		8	9	6	7		9	8	8	5
N/A	4	4	2	2		4	4	1	3		5	3	2	2
Mib-1 index					0.065					0.043					0.068
< 20%	2	3	5	9		2	3	3	11		3	2	6	8
≥ 20%	26	22	22	18		19	29	18	22		28	20	25	15
Unstained TILs					0.198					0.022					< 0.001
Low (≤ 30%)	17	9	15	17		16	12	9	21		22	4	10	22
High (> 30%)	11	16	12	10		9	16	16	8		9	18	21	1

IBC-NST invasive breast carcinoma of no special type, Ca carcinoma, ILC invasive lobular carcinoma, IMP invasive micropapillary carcinoma, N/A not applicable, TILs tumor-infiltrating lymphocytes

χ² test. Italic type indicates a statistically significant difference (p < 0.05)